Role of ER stress in ventricular contractile dysfunction in type 2 diabetes

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Takada, Akifumi ^a   Miki, Takayuki ^a   Kuno, Atsushi ^a   Kouzu, Hidemichi ^a   Sunaga, Daisuke ^a   Itoh, Takahito ^a   Tanno, Masaya ^a   Yano, Toshiyuki ^a   Sato, Tatsuya ^a   Ishikawa, Satoko ^a   Miura, Tetsuji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; GLUCOSE; MESSENGER RNA; PROTEIN SERCA2A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UBIQUITINATION;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CONSCIOUSNESS; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM STRESS; HEMODYNAMICS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; RATS; RATS, INBRED OLETF; RECEPTORS, ADRENERGIC, BETA; RNA, MESSENGER; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SURVIVAL ANALYSIS; UBIQUITINATION; VENTRICULAR DYSFUNCTION;

RATTUS;

EID: 84863109347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039893     Document Type: Article

References (43)

1. Shah AM, Uno H, Køber L, Velazquez EJ, Maggioni AP, et al. (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail 12: 1229-1237.
2. Boudina S, Abel ED, (2007) Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223.
3. Radovits T, Korkmaz S, Loganathan S, Barnucz E, Bömicke T, et al. (2009) Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 297: H125-133.
4. Smith HM, Hamblin M, Hill MF, (2005) Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure. J Mol Cell Cardiol 39: 657-665.
5. Chandler MP, Morgan EE, McElfresh TA, Kung TA, Rennison JH, et al. (2007) Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 293: H1609-1616.
6. Matsushima S, Kinugawa S, Yokota T, Inoue N, Ohta Y, et al. (2009) Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol 297: H409-416.
7. Shiomi T, Tsutsui H, Ikeuchi M, Matsusaka H, Hayashidani S, et al. (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42: 165-172.
8. Greer JJ, Ware DP, Lefer DJ, (2006) Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol 290: H146-153.
9. Vahtola E, Louhelainen M, Forstén H, Merasto S, Raivio J, et al. (2010) Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat. Cardiovascular Diabetology 9: 5.
10. Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, et al. (2010) Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59: 1899-905.
11. Cnop M, Foufelle F, Velloso LA, (2012) Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med 18: 59-68.
12. Lipskaia L, Chemaly ER, Hadri L, Lompre AM, Hajjar RJ, (2010) Sarcoplasmic reticulum Ca2+ ATPase as a therapeutic target for heart failure. Expert Opin Biol Ther 10: 29-41.
13. Xu J, Wang G, Wang Y, Liu Q, Xu W, et al. (2009) Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection. J Cell Mol Med 13: 1499-1512.
14. Miki T, Miura T, Hotta H, Tanno M, Yano T, et al. (2009) Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition. Diabetes 58: 2863-2872.
15. Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, et al. (2002) Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J 16: 1657-1659.
16. Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, et al. (2002) Overexpression of the Sarcoplasmic Reticulum Ca2+-ATPase Improves Myocardial Contractility in Diabetic Cardiomyopathy. Diabetes 51: 1166-1171.
17. Bidasee KR, Zhang Y, Shao CH, Wang M, Patel KP, et al. (2004) Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 53: 463-73.
18. Sakata S, Lebeche D, Sakata Y, Sakata N, Chemaly ER, et al. (2006) Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer. Mol Ther 13: 987-996.
19. Karakikes I, Kim M, Hadri L, Sakata S, Sun Y, et al. (2009) Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a. PLoS ONE 4: e6474.
20. Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, et al. (2010) Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 298: H833-43.
21. Hotta H, Miura T, Miki T, Togashi N, Maeda T, et al. (2010) Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts. Circ Res 106: 129-132.
22. Basseri S, Lhoták S, Sharma AM, Austin RC, (2009) The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res 50: 2486-2501.
23. Clark RJ, McDonough PM, Swanson E, Trost SU, Suzuki M, et al. (2003) Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278: 44230-7.
24. Ceylan-Isik AF, Sreejayan N, Ren J, (2011) Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction. J Mol Cell Cardiol 50: 107-116.
25. Shrikhande GV, Scali ST, da Silva CG, Damrauer SM, Csizmadia E, et al. (2010) O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One 5: e14240.
26. Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE, (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93: 870-875.
27. Di Bonito P, Moio N, Cavuto L, Covino G, Murena E, et al. (2005) Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging. Diabet Med 22: 1720-1725.
28. Zhang L, Cannell MB, Phillips AR, Cooper GJ, Ward ML, (2008) Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy. Diabetes 57: 2158-2166.
29. Belke DD, Swanson EA, Dillmann WH, (2004) Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53: 3201-3208.
30. Rosenkranz S, (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63: 423-432.
31. Sakata S, Lebeche D, Sakata Y, Sakata N, Chemaly ER, et al. (2007) Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. Am J Physiol Heart Circ Physiol 292: H1204-7.
32. Mariani JA, Smolic A, Preovolos A, Byrne MJ, Power JM, et al. (2011) Augmentation of left ventricular mechanics by recirculation-mediated AAV2/1-SERCA2a gene delivery in experimental heart failure. Eur J Heart Fail 13: 247-53.
33. Gwathmey JK, Yerevanian AI, Hajjar RJ, (2011) Cardiac gene therapy with SERCA2a: from bench to bedside. J Mol Cell Cardiol 50: 803-12.
34. Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, et al. (2004) Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110: 705-12.
35. Zhao H, Liao Y, Minamino T, Asano Y, Asakura M, et al. (2008) Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress. Hypertens Res 31: 1977-87.
36. George I, Sabbah HN, Xu K, Wang N, Wang J, (2011) β-Adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines. Cardiovasc Res 91: 447-55.
37. Loo TW, Clarke DM, (2007) Chemical and pharmacological chaperones as new therapeutic agents. Expert Rev Mol Med 9: 1-18.
38. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140.
39. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA, (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3: 1422-1434.
40. Yano T, Miura T, Whittaker P, Miki T, Sakamoto J, et al. (2006) Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair. J Am Coll Cardiol 47: 626-634.
41. Nishihara M, Miura T, Miki T, Tanno M, Yano T, et al. (2007) Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection. J Mol Cell Cardiol 43: 564-570.
42. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, et al. (1999) Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol Heart Circ Physiol 277: H584-594.
43. Lujan HL, DiCarlo SE, (2009) Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats. J Cardiovasc Pharmacol Ther 14: 199-20.